CNClinicalTrials.govClinical trialRecruiting
Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs
Official record
- Identifier
NCT07136701- Recruiting locations
country
China- Interventions studied
- Not provided in the official record
- Lead sponsor
- Qilu Hospital of Shandong University
- Target enrolment
- 600 participants
- Study type
- OBSERVATIONAL
- Phase
- Not provided in the official record
- Status
- Recruiting
- First posted
- Aug 22, 2025
- Last updated on the registry
- Aug 13, 2026
- Age
- 18 Years – 85 Years
- Sex
- ALL
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * 18 years or older; histopathologically confirmed pancreatic neuroendocrine tumor by surgical resection or biopsy. Exclusion Criteria: * Pancreatic neuroendocrine carcinoma; incomplete pathological data; received antitumor treatment prior to presentation; with other malignanies or malignant history.
- Indexed under
- Pancreatic Cancer